A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of TAK-925 in Healthy Volunteers and Participants With Narcolepsy
Clinical trial NCT03748979 · COMPLETED
Trial details
- NCT number
- NCT03748979
- Sponsor
- Takeda
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-11-21
- Primary completion
- 2019-10-24
- Enrollment
- 57
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.